A groundbreaking research initiative is underway, aiming to unravel the mysteries of multiple sclerosis (MS) and its risk factors. The Perron Institute, in collaboration with MS Australia, has embarked on a $2.8 million research grant project, tackling a critical gap in our understanding of MS genetics and potential strategies to manage this debilitating disease.
MS, an immune-mediated condition, is a complex puzzle where the body's own defense mechanisms turn against the brain and spinal cord, damaging the protective myelin coating around nerve fibers. This leads to a range of symptoms, impacting mobility, vision, cognition, and energy levels.
The statistics are alarming: over 37,700 Australians are currently living with MS, a staggering 77.4% increase since 2010. The economic burden of this disease reached a staggering $3 billion in 2024. As these numbers continue to rise, the urgency for accelerated research has never been greater.
One of the key projects under this initiative is led by Dr. Brittney Lins, a Postdoctoral Fellow at Curtin University and the Perron Institute. Dr. Lins is exploring a fascinating hypothesis: could disrupted copper levels in the brain be the missing link connecting major MS risk factors such as Epstein-Barr virus infection, vitamin D deficiency, and gut health?
"Copper, a trace nutrient, plays a critical yet delicate role in our body's energy utilization and antioxidant defenses," explains Dr. Lins. "When copper utilization is disrupted, myelin may become more susceptible to inflammation and autoimmune attacks. I believe copper could be the key to understanding how these various risk factors are interconnected in MS."
Dr. Rebekah Puls, Head of Research at Perron Institute, highlights the significance of this project: "Dr. Lins has been awarded a prestigious fellowship to explore this exciting preclinical project. Recent advancements in synchrotron microscopy now allow us to visualize copper levels in the brain, opening up new avenues for discovery."
"Determining whether copper imbalance is a core factor in MS susceptibility could revolutionize our approach to prevention and treatment."
The project team includes Associate Professor Mark Hackett from Curtin University, and from the Curtin University and Perron Institute Neurotrauma Research group: Professor Lindy Fitzgerald, Dr. Sarah Hellewell, and Dr. Chidozie Anyaegbu.
MS Australia's commitment to research is evident in their investment of over $60 million over the past two decades. CEO Rohan Greenland emphasizes the importance of sustained national investment: "Research gives hope to those living with MS, reminding them that progress is not only possible but within reach."
"The passion and dedication of our Member Organizations, donors, and the broader MS community have made this research possible. Together, we are accelerating the pace of discovery, bringing us closer to a world where MS is a thing of the past."
The research grants will be officially launched at Parliament House in Canberra on March 4th, at MS Australia's Advancing MS Research in Australia event. Speakers, including Dr. Monique Ryan MP and Ms. Renee Coffey MP, will highlight the critical role of national commitment in driving MS research forward.
This article is based on MS Australia's media statement, with images courtesy of Andre Avila at Curtin University.
